Hallucinations and the spectrum of psychosis in Parkinson's disease

Journal of the Neurological Sciences

Volumn 374, Issue , 2017, Pages 56-62

  Frei, Karen ^a   Truong, Daniel D ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b Parkinson's and Movement Disorder Institute   (United States)

Author keywords

Delusions; Hallucinations; Parkinson's disease; Psychosis

Indexed keywords

AUDITORY HALLUCINATION; DELUSION; GUSTATORY HALLUCINATION; HALLUCINATION; HUMAN; OLFACTORY HALLUCINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; TACTILE HALLUCINATION; VISUAL HALLUCINATION; COMPLICATION; HALLUCINATIONS; PSYCHOTIC DISORDERS;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; HALLUCINATIONS; HUMANS; PARKINSON DISEASE; PSYCHOTIC DISORDERS;

EID: 85009816972     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2017.01.014     Document Type: Review

References (76)

1. [1] Chang, A., Fox, S.H., Psychosis in Parkinson's disease: epidemiology, pathophysiology and management. Drugs 76:11 (2016), 1093–1118.
2. [2] Ravina, B., Marder, K., Fernandez, H.H., Friedman, J.H., McDonald, W., Murphy, D., et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov. Disord. 22:8 (2007), 1061–1068.
3. [3] Pagonabarra, J., Martinez-Horta, S., Bobadilla, R.F.D., Perez, J., Robosa-Nogue, R., Marin, J., et al. Minor hallucinations occur in drug-naïve Parkinson's disease patients, even from the premotor phase. Mov. Disord. 31:1 (2016), 45–52.
4. [4] Fenelon, G., Mahieux, F., Huon, R., Ziegler, M., Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 123 (2000), 733–745.
5. [5] Fenelon, G., Soulas, T., Zenashi, F., de Langavant, F.C., The changing face of Parkinson's disease associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov. Disord. 25:6 (2010), 763–766.
6. [6] Williams, D.R., Warren, J.D., Lees, A.J., Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J. Neurol. Neurosurg. Psychiatry 79 (2008), 652–655.
7. [7] Pacchetti, C., Manni, R., Zangaglia, R., Mancine, F., Marchioni, E., Tassorelli, C., et al. Relationship between hallucinations, delusions and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov. Disord. 20:11 (2005), 1439–1448.
8. [8] Fenelon, G., Alves, G., Epidemiology of psychosis in Parkinson's disease. J. Neurol. Sci. 289 (2010), 12–17.
9. [9] Chou, K.L., Messing, S., Oakes, D., Feldman, P.D., Breier, A., et al. Drug-induced psychosis in Parkinson disease. Phenomenology and correlations among psychosis rating instruments. Clin. Neuropharmacol., 2005, 215–219.
10. [10] Fenelon, G., Soulas, T., Langavant, L.C.D., Trinkler, I., Bachoud-Levy, A.C., Feeling of presence in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 82 (2011), 1219–1224.
11. [11] Pagonabarraga, J., Soriano-Mas, C., Llebaria, G., Lopez-Sola, M., Pujol, J., Kulisevsky, J., Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease. Parkinsonism Relat. Disord. 20 (2014), 290–296.
12. [12] Williams, D.R., Lees, A.J., Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol. 4 (2005), 605–610.
13. [13] Sacks, O., Hallucinations. 2012, Random House Inc., New York.
14. [14] Mack, J., Rabins, P., Anderson, K., Goldstein, S., Grill, S., et al. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am. J. Geriatr. Psychiatry 20:2 (2012), 123–132.
15. [15] Svetel, M., Smiljkovic, T., Pekmezovic, T., Kostic, V., Hallucinations in Parkinson's disease: cross-sectional study. Acta Neurol. Belg. 112 (2012), 33–37.
16. [16] Klein, C., Kompf, D., Pulkowski, U., Moser, A., Vieregge, P., A study of visual hallucinations in patients with Parkinson's disease. J. Neurol. 244 (1997), 371–377.
17. [17] Holroyd, S., Currie, L., Wooten, G.F., Prospective study of hallucinations and delusions in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 70 (2001), 734–738.
18. [18] Sanchez-Ramos, J.R., Ortoll, R., Paulson, G.W., Visual hallucinations associated with Parkinson disease. Arch. Neurol. 53 (1996), 1265–1268.
19. [19] Inoue, M., Ueno, S., Background scenery visual hallucinations in a depressed patient with Parkinson's disease. Mov. Disord. 25:6 (2010), 786–787.
20. [20] Vaou, O., Saint-Hilare, M., Friedman, J., Visual hallucinations in photographs in Parkinson's disease. BMJ Case Rep., 22, 2013, 2013.
21. [21] Manford, M., Andermann, F., Complex visual hallucinations. Clinical and neurobiological insights. Brain 121 (1998), 1819–1840.
22. [22] Moskovitz, C., Moses, H., Klawans, H.L., Levodopa-induced psychosis: a kindling phenomenon. Am. J. Psychiatry 135:6 (1978), 669–675.
23. [23] Harding, A.J., Broe, G.A., Halliday, G.M., Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 (2002), 391–403.
24. [24] Onofrj, M., Thomas, A., D'Andreamatteo, G., Iacono, D., Luciano, A.L., Di Rollo, A., et al. Incidence of RBD and hallucinations in patients affected by Parkinson's disease: 8-year follow-up. Neurol. Sci. 23 (2002), S91–S94.
25. [25] Inzelberg, R., Kippervasser, S., Korczn, A.D., Auditory hallucinations in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 64 (1998), 533–535.
26. [26] Factor, S.A., Molho, E.S., Threatening auditory hallucinations and Cotard syndrome in Parkinson's disease. Clin. Neuropharmacol. 27 (2004), 205–207.
27. [27] Nagata, T., Shinagawa, S., Tagai, K., Nakayama, K., A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson's disease. Int. Psychogeriatr. 25:7 (2013), 1199–1201.
28. [28] Mittal, M., Giron, L.T., Elvis is back: musical hallucinations in a Parkinson's disease patient. South. Med. J. 103:8 (2010), 837–840.
29. [29] Ergun, U., Bozbas, A., Akin, U., Inan, L., Musical hallucinations and Parkinson's disease. Neurologist 15 (2009), 1150–1152.
30. [30] Clark, J., Case history of a patient with musical hallucinations and Parkinson's disease. Int. J. Geriatr. Psychiatry 13 (1998), 886–887.
31. [31] Gondim, F.D.A.A., Costa, H.A., Taunay, T.C.D., de Oliveira, G.R., Ferriera, J.M., Rola, F.H., Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease. Mov. Disord. 25:10 (2010), 1505–1526.
32. [32] Kataoka, H., Ueno, S., Auditory musical hallucinations associated with extended release pramipexole in an elderly patient with Parkinson's disease. Medicine (Baltimore), 93(27), 2014, e 251 10.1097.
33. [33] Wand, A., Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression. Aust NZ J. Psychiatry, 46(2), 2012, 178.
34. [34] Bannier, S., Berdague, J.L., Rieu, I., de Chazeron, I., Marques, A., Derost, P., et al. Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 83 (2012), 1019–1021.
35. [35] Landis, B.N., Burkhard, P.R., Phantosmias and Parkinson disease. Arch. Neurol. 65:9 (2008), 1237–1239.
36. [36] Singh, S., Schwankaus, J., Olfactory disturbance in Parkinson's disease. Arch. Neurol. 66:6 (2009), 805–806.
37. [37] McAuley, J.H., Gregory, S., Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease. J. Parkinsons Dis. 2:3 (2012), 199–205.
38. [38] Tousi, B., Frankel, M., Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism Relat. Disord. 10 (2004), 253–254.
39. [39] Fenelon, G., Thobois, S., Bonnet, A.M., Broussolte, E., Tison, F., Tactile hallucinations in Parkinson's disease. J. Neurol. 249:12 (Dec 2002), 1699–1703.
40. [40] Kataoka, H., Sawa, N., Sugie, K., Ueno, S., Can dopamine agonists trigger tactile hallucinations in patients with Parkinson's disease?. J. Neurol. Sci. 347:1–2 (2014), 361–363.
41. [41] Jimenez-Jimenez, F.J., Ortparga, M., Gasalla, T., Tallon-Barranco, A., Cabrera-Valdera, F., Cenesthetic hallucinations in a patient with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 63, 1997, 120.
42. [42] Kiziltan, G., Ozekmekci, S., Ertan, S., Ertan, T., Erginoz, E., Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J. Neurol. 254 (2007), 448–452.
43. [43] Solla, P., Cannas, A., Orofino, G., Marrosu, F., Fluctuating Cotard syndrome in a patient with advanced Parkinson disease. Neurologist 19:3 (2015), 70–72.
44. [44] Moro, A., Munhoz, R.P., Moscovich, M., Arruda, W.U., Teiv, H.A.G., Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease. Parkinsonism Relat. Disord. 19 (2013), 751–754.
45. [45] Cannas, A., Solla, P., Floris, G., Tacconi, P., Marrosu, F., Marrosu, M.G., Othello syndrome in Parkinson disease patients without dementia. Neurologist 15:1 (2009), 34–36.
46. [46] McNamara, P., Durso, R., Reversible pathologic jealousy (Othello syndrome) associated with amantadine. J. Geriatr. Psychiatry Neurol. 4 (1991), 157–159.
47. [47] Hermanowicz, N., A blind man with Parkinson's disease, visual hallucinations and Capgras syndrome. J. Neuropsychiatr. Clin. Neurosci. 14:4 (2002), 462–463.
48. [48] Marsh, L., Williams, J.R., Rocco, M., Grill, S., Munro, C., Dawson, T.M., Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 63 (2004), 293–300.
49. [49] Miwa, H.P., Mizuno, Y., Capgras syndrome in Parkinson's disease. J. Neurol. 248:9 (2001), 804–805.
50. [50] Cercy, S.P., Marasia, J.C., Combined delusional misidentification syndrome in a patient with Parkinson's disease. J. Neuropsychiatr. Clin. Neurosci. 24:1 (2012), E3–E4.
51. [51] Islam, L., Piacentini, S., Soliveri, P., Scarone, S., Gambini, O., Capgras delusion for animal and inanimate objects in Parkinson's disease: a case report. BMC Psychiatry, 15, 2015, 73.
52. [52] Apaydini, H., Benbir, G., Capgras syndrome during the course of Parkinson's disease dementia. J. Neuropsychiatr. Clin. Neurosci., 26(3), 2014, E46.
53. [53] Stewart, J.T., Fregoli syndrome associated with levodopa treatment. Mov. Disord. 23 (2008), 308–309.
54. [54] Kyrtaos, C.R., Stahl, M.C., Esliyer, P., Subramanian, T., Lucassen, E.B., Capgras syndrome in a patient with Parkinson's disease after bilateral subthalamic nucleus deep brain stimulation: a case report. Case Rep. Neurol. 7:2 (2015), 27–53.
55. [55] Cannas, A., Spissu, A., Floris, G.L., Saddi, M.V., Cossu, G., Melis, M., et al. Chronic delusional hallucinatory psychosis in early onset Parkinson's disease: drug-induced complication or sign of an idiopathic psychiatric illness?. Neurol. Sci. 22 (2001), 53–54.
56. [56] Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B.K., Nation, D., et al. A questionnaire-based (UM_PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol., 8, 2008, 21, 10.1186/1471-2377-8-21.
57. [57] Aarsland, D., Larsen, J.P., Cummings, J.L., Laake, K., Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. Arch. Neurol. 56 (1999), 595–601.
58. [58] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fifth ed., 2013.
59. [59] Gordon, P.C., Kauark, R.B.G., Costa, C.D.M., de Oliveira, A.O., Godinho, F.L.F., Rocha, M.S.G., Clinical implications of the National Institute of Neurological Disorders and Stroke criteria for diagnosing psychosis in Parkinson's disease. J. Neuropsychiatr. Clin. Neurosci. 28 (2016), 26–31.
60. [60] Goetz, C.G., Ouyang, B., Negron, A., Stebbins, G.T., Hallucinations and sleep disorders in Parkinson's disease: ten-year prospective longitudinal study. Neurology 57 (2010), 2078–2082.
61. [61] Goetz, C.G., Fan, W., Leurgans, S., Bernard, B., Stebbins, G.T., The malignant course of “benign hallucinations” in Parkinson disease. Arch. Neurol. 63 (2006), 713–716.
62. [62] Goetz, C.G., Stebbins, G.T., Ouyang, B., Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years. Mov. Disord. 26:12 (2011), 2196–2200.
63. [63] Goetz, C.G., Wuu, J., Curgian, L., Leurgans, S., Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patient. Mov. Disord. 21 (2006), 267–270.
64. [64] De Maindreville, A.D., Fenelon, G., Mahieux, F., Hallucinations in Parkinson's disease: a follow-up study. Mov. Disord. 20:2 (2005), 212–216.
65. [65] Forsaa, E.B., Larsen, J.P., Wentzel-Larsen, T., Goetz, C.G., Stebbins, G.T., Aarsland, D., et al. A 12-year population-based study of psychosis in Parkinson's disease. Arch. Neurol. 67:8 (2010), 996–1001.
66. [66] Gibson, G., Motram, P.G., Brown, D.J., Hindle, J.V., Landau, S., Samuel, M., et al. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. Int. J. Geriatr. Psychiatry 28 (2013), 626–631.
67. [67] Dotchin, C.L., Jusabani, A., Walker, R.W., Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania. Parkinsonism Relat. Disord. 15 (2009), 457–460.
68. [68] Goetz, C.G., Pappert, E.J., Blasucci, L.M., Stebbins, G.T., Ling, Z.D., Nora, M.V., et al. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology 50:2 (1998), 515–517.
69. [69] Fenelon, G., Goetz, C.G., Karenberg, A., Hallucinations in Parkinson's disease in the prelevodopa era. Neurology 66 (2006), 93–98.
70. [70] Goetz, C.G., Fan, W., Leurgans, S., Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening. Mov. Disord. 23:11 (2008), 1541–1545.
71. [71] Ojo, O.O., Fernandez, H.H., The current understanding of psychosis in Parkinson's disease. Curr. Psychiatry Rep., 18, 2016, 97.
72. [72] Voon, V., Lang, A.E., Antidepressants in the treatment of psychosis with comorbid depression in Parkinson's disease. Clin. Neuropharmacol. 27:2 (2004), 90–92.
73. [73] Tagai, K., Nagata, T., Shinagawa, S., Tsuno, N., Ozone, M., et al. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report. Psychogeriatrics 13:2 (2013), 103–107.
74. [74] Godschalk-Dekker, J.A., Siegers, H.P., Reduction of parkinsonism and psychosis with mirtazapine: a case report. Pharmacopsychiatry 47:03 (2014), 81–83.
75. [75] Nishioka, K., Tanaka, R., Sumura, H., Hirano, K., Hatano, T., et al. Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms. J. Neural Transm. (Viena) 121:11 (2014), 1405–1410.
76. [76] Taylor, J., Anderson, W.S., Brandt, J., Mari, Z., Pontone, G.M., Neuropsychiatric complications of Parkinson disease treatments: importance of multidisciplinary care. Am. J. Geriatr. Psychiatry 24 (2016), 1171–1180.